Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication-Reference-Cited by-同舟云学术

Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication

Published:2015-07-31 Issue:10 Volume:71 Page:1245-1254
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Wallach-Kildemoes Helle,Hansen Ebba Holme

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-015-1907-y.pdf

Reference29 articles.

1. Kannel WB, Castelli WP, Gordon T, McNamara PM (1971) Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74(1):1–12

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) (1994 Lancet. 344(8934): 1383–1389

3. Ong HT (2005) The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. QJM 98(8):599–614

4. (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106(25): 3143–3421.

5. The most prescribed drugs. 2011. United States. WebMD News archive. 13-6-2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A newly developed algorithm for switching outpatient medications to medications listed in the hospital formulary: a prospective real-word evaluation in patients admitted electively to hospital;European Journal of Clinical Pharmacology;2024-04-24

2. Trends in the utilisation of lipid-lowering medications in Australia: an analysis of national pharmacy claims data;Current Problems in Cardiology;2021-05

3. Comparative analysis of the use of lipid modifying agents in the Republic of Serbia and Nordic countries in the period 2015-2017;Hospital Pharmacology - International Multidisciplinary Journal;2020

4. Lipid-lowering drug prescriptions in a group of Colombian patients;Biomédica;2019-12-01

5. Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study;Lipids in Health and Disease;2018-01-08